NCT05228158 2026-01-02A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in JapanEisai Inc.Active not recruiting145 enrolled